CELEX: 62019TA0688
Language: en
Date: 2022-03-02 00:00:00
Title: Case T-688/19: Judgment of the General Court of 2 March 2022 — VeriGraft v Eismea (Arbitration clause — Grant agreement concluded in the context of the ‘Horizon 2020’ Framework Programme for Research and Innovation — Termination of the agreement — Misconduct — Capacity as beneficiary of the grant or as a natural person acting in his or her name or on his or her behalf)

10.5.2022   
            
            
               EN
            
            
               Official Journal of the European Union
            
            
               C 191/26
            
         
      Judgment of the General Court of 2 March 2022 — VeriGraft v Eismea
      (Case T-688/19) (1)
      
      (Arbitration clause - Grant agreement concluded in the context of the ‘Horizon 2020’ Framework Programme for Research and Innovation - Termination of the agreement - Misconduct - Capacity as beneficiary of the grant or as a natural person acting in his or her name or on his or her behalf)
      (2022/C 191/34)
      Language of the case: English
      
         Parties
      
      
         Applicant: VeriGraft AB (Gothenburg, Sweden) (represented by: P. Hansson and A. Johansson, lawyers)
      
         Defendant: European Innovation Council and SMEs Executive Agency (represented by: A. Galea, acting as Agent, and by D. Waelbroeck and A. Duron, lawyers)
      
         Re:
      
      Application based on Article 272 TFEU seeking a declaration of invalidity of the termination by the Executive Agency for Small and Medium-sized Enterprises (EASME) of the grant agreement concerning the project ‘Personalised Tissue Engineered Veins as the first Cure for Patients with Chronic Venous Insufficiency — P TEV’, concluded in the context of the instrument to support innovation in small and medium-sized enterprises of Horizon 2020 — the Framework Programme for Research and Innovation (2014-2020).
      
         Operative part of the judgment
      
      The Court:
      
                  1.
               
               
                  Declares that the termination by the Executive Agency for Small and Medium-sized Enterprises of the grant agreement for the project ‘Personalised Tissue Engineered Veins as the first Cure for Patients with Chronic Venous Insufficiency — P-TEV’, bearing reference 778620, is invalid;
               
            
                  2.
               
               
                  Orders the European Innovation Council and SMEs Executive Agency to pay the costs.
               
            
         (1)  OJ C 432, 23.12.2019.